Castle Biosciences Inc. (CSTL) Tops Q2 EPS by 70c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts CSTL Hot Sheet
Join SI Premium – FREE
Castle Biosciences Inc. (NASDAQ: CSTL) reported Q2 EPS of ($0.06), $0.70 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $34.84 million versus the consensus estimate of $28.37 million.
For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kosmos Energy (KOS) Misses Q3 EPS by 3c
- B.Riley Reiterates Buy Rating on Redwire (RDW)
- Gates Industrial Corp. (GTES) PT Lowered to $28 at Wells Fargo
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
